Publication Date: August 16, 2024 Published By: Investing.com Article Link: https://www.investing.com/ California-based NeOnc’s groundbreaking nasal spray technology, which uses the olfactory nerve pathway to deliver life-saving cancer drugs directly to the brain, has won the Drug Delivery Technology of the Year award, marking a significant advancement in cancer treatment. NeOnc Executive Team: (l-r) Pat Walters, […]
Publication Date: August 16, 2024 Published By: Pharma Tech Outlook Article Link: https://www.pharmatechoutlook.com/neonc Glioblastoma is recognized as the most aggressive form of brain cancer in adults, with an approximate survival duration of 15 to 18 months, even with the best available treatment. The critical hurdle hindering most medication from reaching the desired site of action […]
Publication Date: August 9, 2024 Published By: Healio Article Link: https://www.healio.com/news/neurology/20240809/qa-groundbreaking-intranasal-brain-cancer-treatment-bypasses-bloodbrain-barrier#:~:text=Traditional%20chemotherapy%20and%20targeted%20therapies,target%20tumor%20cells%20more%20effectively. Bypassing the blood-brain barrier remains an obstacle for novel therapeutics. Healio spoke to Thomas Chen, MD, PhD, founder and CEO of NeOnc, to find out how a novel nasal spray formulation to treat brain cancer overcomes these challenges. Healio: How and why was the […]
Publication Date: August 6, 2024 Published By: Breaking Cancer News Article Link: https://breakingcancernews.com/2024/08/06/a-new-company-and-new-approach-to-brain-cancer/ Jamie Reno – Editor in Chief of Breaking Cancer News We are finally seeing some genuine progress in treating brain cancer, with new treatments and trials going on nationwide and worldwide. This week, I write about one company that’s moving the needle, […]
Publication Date: August 6, 2024 Published By: USA Today Article Link: https://www.usatoday.com/story/special/contributor-content/2024/08/06/meet-the-surgeon-leading-a-biotech-revolution-dr-thomas-chens-fight-against-brain-cancer/74687948007/ Dr. Thomas Chen Many people think of a cure for cancer as a single medical breakthrough, but in all likelihood, it will be a combination of medical and biotech innovations. NeOnc, Inc., a biotech company headed by neurosurgeon Dr. Thomas Chen, has developed […]
Publication Date: August 6, 2024 Published By: Breaking Cancer News Article Link: https://breakingcancernews.com/2024/08/06/neonc-a-new-company-and-new-approach-to-brain-cancer/ When you’re a journalist and you learn you have cancer, one would think that you would use whatever research talents you possess to learn as much as you can about the disease. But at the beginning of my first go-round with cancer, […]
NeOnc’s second concurrent Phase 2 clinical study seeks further safety and preliminary evidence of the biological effects of its lead drug candidate, NEO100™, on certain cancers of the brain and central nervous system. Generated by NeOnc’s patented NEO™ technology platform, NEO100-02™ for meningioma indications is intended to target such tumors that occur in membranes […]
Publication Date: August 2, 2024 Published By: The Cancer Letter Article Link: https://cancerletter.com/in-brief/20240802_7f/ NeOnc Technologies Holdings Inc., a clinical-stage biopharmaceutical company, has received the Breakthrough Medical Technology Achievement Award from the California Investment Forum for its innovations in medical technology related to the treatment of brain and central nervous system diseases. The award was presented […]
